253 related articles for article (PubMed ID: 21630470)
1. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
2. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
[TBL] [Abstract][Full Text] [Related]
3. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
Cubo L; Hambley TW; Sanz Miguel PJ; Carnero A; Navarro-Ranninger C; Quiroga AG
Dalton Trans; 2011 Jan; 40(2):344-7. PubMed ID: 20936210
[TBL] [Abstract][Full Text] [Related]
4. The second generation of iodido complexes: trans-[PtI2(amine)(amine')] bearing different aliphatic amines.
Parro T; Medrano MA; Cubo L; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
J Inorg Biochem; 2013 Oct; 127():182-7. PubMed ID: 23688840
[TBL] [Abstract][Full Text] [Related]
5. Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.
Piccinonna S; Margiotta N; Pacifico C; Lopalco A; Denora N; Fedi S; Corsini M; Natile G
Dalton Trans; 2012 Aug; 41(32):9689-99. PubMed ID: 22782180
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
7. On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum.
Sanz Miguel PJ; Roitzsch M; Yin L; Lax PM; Holland L; Krizanovic O; Lutterbeck M; Schürmann M; Fusch EC; Lippert B
Dalton Trans; 2009 Dec; (48):10774-86. PubMed ID: 20023907
[TBL] [Abstract][Full Text] [Related]
8. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA.
Quiroga AG
J Inorg Biochem; 2012 Sep; 114():106-12. PubMed ID: 22819649
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
Wagner G; Marchant A; Sayer J
Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
[TBL] [Abstract][Full Text] [Related]
10. Pt(II)-activated coupling of aminoethylferrocene with benzonitrile. A facile access route to a new redox-active bis(ferrocenyl-amidine) anion sensor.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Kaifer AE; Cuadrado I
Chem Commun (Camb); 2011 Oct; 47(37):10398-400. PubMed ID: 21845259
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of cis-platinum(II) cycloaliphatic amidine complexes: Ring size and solvent effects on the biological activity.
Marzano C; Sbovata SM; Gandin V; Michelin RA; Venzo A; Bertani R; Seraglia R
J Inorg Biochem; 2009 Aug; 103(8):1113-9. PubMed ID: 19560209
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma.
Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D
ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407
[TBL] [Abstract][Full Text] [Related]
13. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
15. Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)].
Margiotta N; Ranaldo R; Intini FP; Natile G
Dalton Trans; 2011 Dec; 40(48):12877-85. PubMed ID: 22064914
[TBL] [Abstract][Full Text] [Related]
16. New Platinum (II) Ternary Complexes of Formamidine and Pyrophosphate: Synthesis, Characterization and DFT Calculations and
Soliman AA; Attaby FA; Alajrawy OI; Abou-Hussein AAA; Linert W
Comb Chem High Throughput Screen; 2020; 23(7):611-623. PubMed ID: 32067614
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.
Sinisi M; Gandin V; Saltarella T; Intini FP; Pacifico C; Marzano C; Natile G
J Biol Inorg Chem; 2014 Oct; 19(7):1081-97. PubMed ID: 24850131
[TBL] [Abstract][Full Text] [Related]
18. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
Ahmad S
Chem Biodivers; 2010 Mar; 7(3):543-66. PubMed ID: 20232326
[TBL] [Abstract][Full Text] [Related]
19. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
